Saturday marks three years since the Capitol insurrection, and Donald Trump has only gotten more extreme as he closes in on the 2024 Republican nomination.
El presidente Biden ha otorgado indultos ampliados para aquellos condenados por posesión simple de cannabis, intento de posesión simple de cannabis o consumo de cannabis en tierras federales y en Washington D.C.
También concedió el indulto a 11 personas que cumplían lo que la Casa Blanca llamó sentencias “desproporcionadamente largas” por delitos de drogas no violentos.
Las acciones del presidente no liberarán a ningún prisionero federal, pero eliminarán las barreras a la vivienda, el empleo y las oportunidades educativas para los condenados por esos delitos.
Eli Lilly, Sanofi, and Novo Nordisk’s price cuts are expected to benefit many Nevadans who need insulin to survive. The companies first announced the moves last year, as a response to an American Rescue Plan provision that threatened to penalize them if they kept prices high.
The president’s actions will not release any federal prisoners, but will lift barriers to housing, employment, and educational opportunities for those convicted of the offenses.
About 250,000 households in Nevada have enrolled in President Biden’s Affordable Connectivity Program, which provides discounts on internet bills.
While the pay bump will affect the 12,273 active duty service members in Nevada, this year’s National Defense Authorization Act is just the latest example of the increasingly partisan landscape of modern American politics.
“Nevada is leading the way in clean energy, bringing in thousands of good-paying jobs and supporting working families throughout my state,” Nevada Senator Catherine Cortez Masto said in a statement in response to the report.
In Missouri, Republicans have introduced bills to charge women who have abortions with murder, while in Texas, a mom was forced to flee the state to get an abortion in order to protect her own health—situations made possible by Donald Trump and the repeal of Roe v. Wade.
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
